Squawk on the Street
SOTS 2nd Hour: Nvidia in Correction Territory, Trump Takes Aim at PBMs, CNBC Fed Survey 12/17/24
Dec 17, 2024
Vamil Devan, a Guggenheim Securities analyst specializing in the pharmaceutical sector, dives into pressing market dynamics. He discusses Nvidia's alarming plunge into correction territory and its implications for investors. Devan also analyzes President-elect Trump’s critique of pharmacy benefit managers, poised to reshape drug pricing strategies. With insights on Pfizer’s future amidst market pressures and evolving healthcare innovations, the conversation highlights a cautious outlook for major health companies facing heightened scrutiny.
43:33
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- The stock market is facing volatility, with Nvidia entering correction territory and overall market sentiment impacted by economic indicators.
- President-elect Trump's criticisms of pharmacy benefit managers highlight ongoing concerns about drug costs and their influence on stock performance for major healthcare companies.
Deep dives
Career Transition and Reskilling
Lisa Schneider plans to leave her office job in ten years to pursue her passion for dog rescue, highlighting the impact of reskilling courses offered by AARP. These courses aim to equip individuals with the skills needed to sustain their income throughout their lives, enabling them to transition to new careers. This change reflects a growing trend among workers seeking fulfilling second acts in their professional lives. The emphasis on early participation in such programs underscores the importance of planning for future career shifts.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
